By Associate Professor Yeh Chen Lee

Journal articles

Williamson JP; Twaddell SH; Lee YCG; Salamonsen M; Hew M; Fielding D; Nguyen P; Steinfort D; Hopkins P; Smith N; Grainge C, 2017, 'Thoracic ultrasound recognition of competence: A position paper of the Thoracic Society of Australia and New Zealand', Respirology, 22, pp. 405 - 408, http://dx.doi.org/10.1111/resp.12977

Lee YC; Lheureux S; Oza AM, 2017, 'Treatment strategies for endometrial cancer: Current practice and perspective', Current Opinion in Obstetrics and Gynecology, 29, pp. 47 - 58, http://dx.doi.org/10.1097/GCO.0000000000000338

Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG, 2017, 'Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.', JAMA, 318, pp. 1903 - 1912, http://dx.doi.org/10.1001/jama.2017.17426

Brown SGA; Ball EL; Perrin K; Read CA; Asha SE; Beasley R; Egerton-Warburton D; Jones PG; Keijzers G; Kinnear FB; Kwan BCH; Lee YCG; Smith JA; Summers QA; Simpson G; Lee YC, 2016, 'Study protocol for a randomised controlled trial of invasive versus conservative management of primary spontaneous pneumothorax', BMJ Open, 6, pp. e011826, http://dx.doi.org/10.1136/BMJOPEN-2016-011826

Lee YC; Michael M; Zalcberg JR, 2015, 'An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer', Expert Opinion on Investigational Drugs, 24, pp. 1307 - 1320, http://dx.doi.org/10.1517/13543784.2015.1070483

Birnie KA; Yip YY; Ng DCH; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YCG; Thompson PJ; Mutsaers SE; Badrian B, 2015, 'Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma', Molecular Cancer Research, 13, pp. 1106 - 1118, http://dx.doi.org/10.1158/1541-7786.MCR-14-0442

Fysh ETH; Thomas R; Read CA; Lam BCH; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DCL; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YCG, 2014, 'Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis', BMJ Open, 4, pp. e006757, http://dx.doi.org/10.1136/bmjopen-2014-006757

Fysh ETH; Tremblay A; Feller-Kopman D; Mishra EK; Slade M; Garske L; Clive AO; Lamb C; Boshuizen R; Ng BJ; Rosenstengel AW; Yarmus L; Rahman NM; Maskell NA; Lee YCG, 2013, 'Clinical Outcomes of Indwelling Pleural Catheter-Related Pleural Infections An International Multicenter Study', Chest, 144, pp. 1597 - 1602, http://dx.doi.org/10.1378/chest.12-3103

Oh SY; Griffiths D; John T; Lee YC; Yu LM; McCarthy N; Heath PT; Crook D; Ramsay M; Richard Moxon E; Pollard AJ, 2008, 'School-aged children: A reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom', Journal of Infectious Diseases, 197, pp. 1275 - 1281, http://dx.doi.org/10.1086/586716

Yeh CL; Kelly DF; Yu LM; Slack MPE; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ, 2008, 'Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody', Clinical Infectious Diseases, 46, pp. 186 - 192, http://dx.doi.org/10.1086/524668

Lee YC; Newport MJ; Goetghebuer T; Siegrist CA; Weiss HA; Pollard AJ; Marchant A, 2006, 'Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins', Vaccine, 24, pp. 5335 - 5340, http://dx.doi.org/10.1016/j.vaccine.2006.04.021

Johnson NG; Ruggeberg JU; Balfour GF; Lee YC; Liddy H; Irving D; Sheldon J; Slack MPE; Pollard AJ; Heath PT, 2006, 'Haemophilus influenzae type b reemergence after combination immunization', Emerging Infectious Diseases, 12, pp. 937 - 941, http://dx.doi.org/10.3201/eid1206.051451

Conference Papers

Nishio S; Pardo B; Hudson E; Rulli E; Antill Y; Lee C; Rabaglio M; Heitz F; Leitner K; Lai C-H; Uggeri S; Manso L; Harano K; Allan K; Lee YC; Tognon G; Canova S; Petrella MC; Gadducci A; Colombo N, 2024, '523 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of AtTEnd/ENGOT-EN7 trial', in International Journal of Gynecological Cancer, Elsevier, pp. a20 - a21, http://dx.doi.org/10.1136/ijgc-2024-esgo.26

Colombo N; Harano K; Hudson E; Galli F; Antill Y; Choi CH; Rabaglio M; Marmé F; Petru E; Lai C-H; Biagioli E; Fariñas-Madrid L; Takehara K; Allan K; Lee YC; Piovano E; Zamagni C; Tasca G; Ferrero A; Barretina-Ginesta M-P, 2024, '546 AtTEnd/ENGOT-EN7: phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma', in International Journal of Gynecological Cancer, Elsevier, pp. a21, http://dx.doi.org/10.1136/ijgc-2024-esgo.27

Buchanan D; Joo J-HE; Mahmood K; Georgeson P; Walker R; Robledo K; Cummins M; Spurdle AB; Smith D; Clendenning M; Como J; Preston S; Yip S; Andrews J; Kok P-S; Lee YC; Stockler M; Mileshkin L; Antill Y, 2024, '713 The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601)', in International Journal of Gynecological Cancer, Elsevier, pp. a504, http://dx.doi.org/10.1136/ijgc-2024-esgo.988

Oaknin A; Lorusso D; Pietzner K; Lee J-Y; Cibula D; Lee YC; Schilder R; Auranen A; Gao B; Tan D; Oza A; Miller R; Salutari V; Tasca G; O’Malley D; Monk B; Pothuri B; Lu L; Berman C; Borgman A; Naumann RW, 2024, 'TP010/#1537  Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: the reframe-01 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase 2/3 study', in International Journal of Gynecological Cancer, Elsevier, pp. a351, http://dx.doi.org/10.1136/ijgc-2024-igcs.612

Werner B; Powell E; Duggan J; Lee YC; Athavale R; Dean M; Warton K; Ford C, 2023, 'Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, BMJ PUBLISHING GROUP, pp. A32 - A33, http://dx.doi.org/10.1136/ijgc-2023-IGCS.47

Au-Yeung G; Bressel M; Prall O; Opar P; Andrews J; Mongta S; Lee YC; Gao BO; Meniawy T; Baron-Hay S; Black A; Kichenadasse G; Ananda S; Fox P; Bowtell D; Mileshkin L, 2023, 'PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification', in International Journal of Gynecological Cancer, Elsevier, pp. a2 - a3, http://dx.doi.org/10.1136/ijgc-2023-igcs.3

Mileshkin LR; Moore KN; Barnes EH; Lee YC; Gebski V; Narayan K; Bradshaw N; Diamante K; Fyles AW; Small W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Carlson M; Robison K; Rischin D; Stockler MR; Monk BJ, 2022, 'Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 03 June 2022 - 07 June 2022

Sivakumaran T; Krasovitsky M; Lee YC; Norris C; Friedlander M, 2020, '403 Treatment patterns post PARP inhibitor in epithelial ovarian cancer patients: results from an Australian, retrospective, multi-institute cohort study', in International Journal of Gynecological Cancer, Elsevier, pp. a167, http://dx.doi.org/10.1136/ijgc-2020-igcs.348

Wilson MK; Lheureux S; Cyriac S; Dhani NC; Butler M; Gutierrez D; Mandilaras V; Ethier J-L; Colombo I; Lee YC; Kanjanapan Y; Bonilla L; Hunt W; Bowering V; Oza AM, 2017, 'Clinical trial of biopsies in oncology: Patient-reported impact (BIOPSY).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e17034

Colombo I; Lien S; Yang C; Clouthier DL; Bonilla L; Cyriac S; Ethier J-L; Lee YC; Kanjanapan Y; Mandilaras V; Dhani NC; Butler MO; Oza AM; Quintos J; Chow H; Pugh TJ; Ohashi PS; Siu LL; Lheureux S, 2017, 'Immunologic and genomic characterization of high grade serous ovarian cancer (HGSOC) in patients (pts) treated with pembrolizumab (Pembro) in the phase II INSPIRE trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.5581

Lee YC; Milne RL; Smith C; Picken S; Camm S; McLachlan S-A; Friedlander M; Hopper JL; Phillips K-A, 2016, 'Risk of uterine cancer in BRCA1 and BRCA2 mutation carriers.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 03 June 2016 - 07 June 2016, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.1529

Birnie KA; Yip Y; Ng D; Kirschner MB; Reid G; Thompson PJ; Lee YC; Badrian B; Mutsaers SE, 2015, 'LOSS OF MICRORNA-223 AND C-JUN-TERMINAL KINASE (JNK) SIGNALLING CONTRIBUTE TO THE OVER-EXPRESSION OF STATHMIN IN MALIGNANT PLEURAL MESOTHELIOMA', in RESPIROLOGY, WILEY-BLACKWELL, AUSTRALIA, Queensland, pp. 146 - 146, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400379&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rosenstengel A; Tremblay A; Slade M; Garske L; Ng B; Lamb C; Clive A; Mishra E; Boshuizen R; Fysh E; Lee YCG, 2013, 'PLEURAL INFECTIONS ASSOCIATED WITH INDWELLING PLEURAL CATHETERS (IPC)', in RESPIROLOGY, WILEY-BLACKWELL, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Lheureux S; Abelson S; Bauer S; Fabre M; Bernardini M; Plante M; Provencher D; Brand A; Cohen P; Dawson L; Lackie E; Lee YC; Altman A; Lapointe-Milot K; Friedlander M; Brar H; Kim R; Brenton J; Reynolds A; Tu D; Parulekar W; Pugh T; Oza A, 2026, 'Prevalence of clonal hematopoiesis (CH) in BRCA 1/2 mutation carriers enrolled in a randomized prevention trial of acetylsalicylic acid (ASA) – The STICS and STONES study (CCTG-OV25)', in Gynecologic Oncology, Elsevier, Vol. 208, pp. s335 - s336, http://dx.doi.org/10.1016/j.ygyno.2026.01.582

Nahm SH; Kiely BE; O'Connell RL; Lee YC; Davis A; Avall-Lundqvist E; Berek JS; Berton D; Donnellan P; Hilpert F; Joly F; Lanceley A; Ledermann JA; Okamoto A; Oza A; Pignata S; Sehouli J; King MT; Friedlander M; Stockler MR; Roncolato FT, 2025, 'Prognostic significance and accuracy of oncologists’ estimates of survival time in recurrent ovarian cancer', in International Journal of Gynecological Cancer, Vol. 35, http://dx.doi.org/10.1016/j.ijgc.2024.100030

Haggstrom L; Lee YC; Ginesta MPB; Jaeger A; Kaiser S; Woopen H; Rhind M; Frenel J-S; Hussain A; Bischof K; Mongillo M; Brodsky AL; Ledermann JA; Ghezelayagh T; Boere IA; Alonso CM; Rosengarten OS; Tucker KM; Friedlander ML; Inhibitors GCICIERTP, 2025, '1077P How long is long enough? An international GCIG collaboration investigating long term outcomes of exceptional responders with platinum sensitive recurrent ovarian cancer treated with PARP inhibitors', in Annals of Oncology, Elsevier, Vol. 36, pp. s722 - s723, http://dx.doi.org/10.1016/j.annonc.2025.08.1715

Nicum S; Ledermann JA; Friedlander ML; Mileshkin L; Lee YC; King MT; Mercieca-Bebber R; Smith J; Wilkinson K; Counsell N, 2025, '1089P Telling it as it is: Quality of life outcomes associated with maintenance olaparib and cediranib following a response to chemotherapy in relapsed platinum-sensitive ovarian cancer', in Annals of Oncology, Elsevier, Vol. 36, pp. s728 - s729, http://dx.doi.org/10.1016/j.annonc.2025.08.1727

Mercieca-Bebber R; Barnes E; Moore K; Diamante K; Lee YC; Narayan K; Khaw P; Buck M; Brooks S; Lea J; Stuckey A; Lad TE; Holschneider C; Spirtos N; Boyd L; Fyles A; Monk B; Stockler M; King MT; Mileshkin L, 2025, '1172P The relationship between patient-reported outcomes and clinician-rated toxicity in participants with locally advanced cervix cancer in the OUTBACK trial', in Annals of Oncology, Elsevier, Vol. 36, pp. s772 - s773, http://dx.doi.org/10.1016/j.annonc.2025.08.1808

Hayes S; Obermair A; Spence R; Mileshkin L; Davis A; Brand A; Barnes E; Collins L; Andrews J; Janda M; Vagenas D; Adams D; Lee YC; Beesley V; Webb P; Friedlander M; O'Neille H; Williams M; Stockler M, 2025, 'EXERCISE THERAPY ADDED TO FIRST-LINE CHEMOTHERAPY FOR OVARIAN CANCER: EFFECTS ON PROGRESSION-FREE SURVIVAL AND PHYSICAL WELLBEING IN THE RANDOMISED, PHASE 3 ECHO TRIAL (ANZGOG1304/CTC121)', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, ELSEVIER, Vol. 35, http://dx.doi.org/10.1016/j.ijgc.2025.102735

Naidoo M; Scott CL; McNally O; Rome R; Perera S; Lee YC; Whitely A; Burling M; Anderson L; Cohen P; Richardson GE; Friedlander M; Brand A; Hyde S; Bunting M; Jobling T; Zalcberg JR, 2024, 'Overall survival and patterns of care for women with rare ovarian cancers: A prospective study from the Australian National Gynae-Oncology Registry (NGOR)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 42, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford C, 2024, 'Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in Journal of Clinical Oncology, American Society of Clinical Oncology, Vol. 42, presented at 2024 ASCO Annual Meeting, 29 May 2024 - 29 May 2024, http://dx.doi.org/10.1200/JCO.2024.42.16_suppl.5547

Symons R; Heath F; Duggan J; Bui KT; Byun L; Friedlander M; Lee YC, 2024, 'Rates of paclitaxel hypersensitivity reactions using a modified Markman’s infusion protocol as primary prophylaxis', in Supportive Care in Cancer, Vol. 32, http://dx.doi.org/10.1007/s00520-024-08460-z

Klingberg D; Bae S; Zhou D; Sim H-W; Cai R; Anazodo A; Grimison PS; Lewis CR; Lee YC, 2022, 'Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 11570 - 11570, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.11570

Au-Yeung G; Bressel M; Prall O; Surace D; Andrews J; Mongta S; Lee YC; Gao B; Meniawy T; Baron-Hay SE; Black AJ; Kichenadasse G; Ananda S; Fox P; Bowtell D; Mileshkin LR, 2022, 'IGNITE: A phase II signal-seeking trial of adavosertib targeting recurrent high-grade, serous ovarian cancer with cyclin E1 overexpression with and without gene amplification.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 5515 - 5515, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.5515

Mileshkin LR; Moore KN; Barnes EH; Lee YC; Gebski V; Narayan K; Bradshaw N; Diamante K; Fyles AW; Small W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Carlson M; Robison K; Rischin D; Stockler MR; Monk BJ, 2022, 'Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 5531 - 5531, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.5531

Pitiyarachchi O; Lee YC; Ramus SJ; deFazio A; Friedlander M, 2022, 'Rates of somatic variants in homologous recombination DNA repair deficiency genes in older patients with high-grade serous ovarian carcinoma', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 30 - 30

Smith D; Robledo K; Yip S; Cummins M; Kok P-S; Lee YC; Friedlander M; Baron-Hay SE; Shannon CM; Coward J; Beale PJ; Goss G; Meniawy T; Lombard JM; Spurdle AB; Andrews J; Stockler MR; Mileshkin LR; Antill YC, 2021, 'Tumor-associated immune cells and progression-free survival in advanced endometrial cancer (EC), results from the PHAEDRA trial (ANZGOG 1601).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 39, presented at Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 04 June 2021 - 08 June 2021, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.5584

Scott C; Lee CK; Lee YC; Friedlander M; Hollis S; Diamante K; Davies C; Stockler M; Plebanski M, 2019, 'SOLACE2: A phase II randomised trial of immune priming by olaparib-cyclophosphamide prior to olaparib-durvalumab in asymptomatic, platinum-sensitive recurrent ovarian cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 160 - 161, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Mileshkin LR; Moore KN; Barnes EH; Gebski V; Narayan K; King MT; Bradshaw N; Lee YC; Diamante K; Fyles AW; Small Jr. W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Mathews CA; Buck M; Suder A; Lad TE; Barani IJ; Holschneider CH; Van Dyk S; Quinn M; Rischin D; Monk BJ; Stockler MR, 2023, Adjuvant Chemotherapy Following Chemo-Radiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemo-Radiation Alone: The Randomised Phase 3 OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274), http://dx.doi.org/10.2139/ssrn.4335106

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford CE, Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer, http://dx.doi.org/10.1101/2024.03.09.24303840

Back to profile page